Legal Representation
Attorney
Randy M. Friedberg
USPTO Deadlines
Next Deadline
32 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
August 13, 2025
Extension Available
Until February 13, 2025
Application History
26 eventsDate | Code | Type | Description |
---|---|---|---|
Feb 6, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 6, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED |
Feb 5, 2025 | EXT2 | S | SOU EXTENSION 2 FILED |
Feb 5, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 5, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Feb 5, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Feb 5, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Feb 5, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Aug 9, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
Aug 9, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
Aug 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Feb 13, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Dec 19, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Dec 19, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Nov 29, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Nov 14, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Oct 24, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 23, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 23, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jul 24, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 24, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jul 24, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 13, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 19, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 6, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Software as a service (SAAS) services featuring software for data analytics related to patients, clinical trial management, management and centralization of multiple data sources for medical and healthcare organizations, pharmacovigilance management, and regulatory compliance management in the field of life sciences and healthcare industry
Additional Information
Pseudo Mark
FRONTIER IQ
Classification
International Classes
042